Acetylcysteine (NAC)
Mucolytic agent — breaks down thick mucus for easier breathing
Acetylcysteine, also known as N-acetylcysteine (NAC), is a mucolytic medication that thins and loosens thick, sticky mucus in the airways. It is primarily prescribed for chronic bronchitis and other chronic respiratory conditions. Beyond its mucolytic role, acetylcysteine is the standard-of-care antidote for paracetamol (acetaminophen) poisoning and is being researched for a growing number of other clinical applications.
Quick Facts
Key Takeaways
- Acetylcysteine works by breaking disulfide bonds in mucoproteins, reducing the viscosity of bronchial mucus so it can be coughed up more easily.
- Available as 200 mg and 600 mg effervescent tablets — dissolve completely in half a glass of water before drinking.
- Beyond its mucolytic action, acetylcysteine serves as a critical antidote for paracetamol overdose by replenishing hepatic glutathione stores.
- Patients with asthma or a history of bronchospasm should inform their doctor before starting treatment, as acetylcysteine may rarely trigger airway narrowing.
- Common side effects are mild gastrointestinal symptoms (diarrhea, nausea); serious allergic reactions such as angioedema are rare but require immediate medical attention.
What Is Acetylcysteine and What Is It Used For?
Quick Answer: Acetylcysteine (NAC) is a mucolytic medicine that breaks down thick, tenacious mucus in the lungs and airways. It is primarily used for chronic bronchitis and chronic obstructive pulmonary disease (COPD) where excessive mucus production impairs breathing.
Acetylcysteine, commonly abbreviated as NAC (N-acetylcysteine), belongs to the class of mucolytic agents. These medications work by modifying the chemical structure of mucus to make it thinner and less viscous. Acetylcysteine accomplishes this through its free sulfhydryl (thiol) group, which cleaves the disulfide bonds that give mucus its thick, gel-like consistency. The resulting reduction in mucus viscosity makes it significantly easier to expectorate, relieving the feeling of congestion and improving airway clearance.
The primary indication for oral acetylcysteine is the management of chronic bronchitis — a long-standing inflammatory condition of the bronchial tubes characterized by persistent cough and excessive sputum production. In clinical practice, it is widely prescribed for patients with COPD who experience frequent exacerbations associated with tenacious secretions. The European Respiratory Society (ERS) and the American Thoracic Society (ATS) have acknowledged the potential role of mucolytics in reducing the frequency and duration of COPD exacerbations, particularly in patients not already receiving inhaled corticosteroids.
Acetylcysteine is listed on the World Health Organization (WHO) Model List of Essential Medicines, underscoring its importance in global healthcare. The WHO listing primarily relates to its role as an antidote for paracetamol (acetaminophen) poisoning, where intravenous acetylcysteine is the gold-standard treatment. By serving as a precursor to glutathione — the body's principal intracellular antioxidant — acetylcysteine replenishes depleted hepatic glutathione stores and prevents the accumulation of the toxic metabolite NAPQI, thereby protecting the liver from potentially fatal damage.
Research interest in acetylcysteine extends well beyond its established indications. Ongoing clinical trials and systematic reviews are investigating its potential benefits in a range of conditions, including idiopathic pulmonary fibrosis, psychiatric disorders (obsessive-compulsive disorder, substance use disorders), contrast-induced nephropathy, and as an adjunct in the management of certain viral respiratory infections. While some of these applications show promise, they remain investigational and are not yet supported by sufficient evidence for routine clinical use.
What Should You Know Before Taking Acetylcysteine?
Quick Answer: Do not take acetylcysteine if you are allergic to it or any of its ingredients. Use with caution if you have asthma, a history of bronchospasm, peptic ulcer disease, or histamine intolerance. Inform your doctor about all other medications you are taking.
Contraindications
The primary contraindication for acetylcysteine is known hypersensitivity (allergy) to the active substance or to any of the excipients contained in the formulation. If you have experienced an allergic reaction to acetylcysteine in the past — such as skin rash, itching, facial swelling, or breathing difficulties — you must not take this medicine again. Inform your doctor or pharmacist of any previous adverse reactions to medications.
Effervescent tablet formulations typically contain excipients including lactose, sodium bicarbonate, citric acid, mannitol, ascorbic acid, saccharin sodium, and flavoring agents (which may contain sorbitol). Patients with rare hereditary conditions such as galactose intolerance, total lactase deficiency, or glucose-galactose malabsorption should not take formulations containing lactose without medical advice.
Warnings and Precautions
Several important precautions should be observed before and during treatment with acetylcysteine. The following groups of patients require special vigilance:
- Asthma and bronchospasm: If you have a diagnosis of asthma or have ever experienced bronchospasm (sudden narrowing of the airways), inform your doctor before starting acetylcysteine. Although uncommon, mucolytic agents can occasionally trigger bronchospasm in susceptible individuals. Your doctor may choose to monitor your lung function closely or select an alternative therapy.
- Skin and mucosal reactions: If you develop any new skin reactions — including rash, blistering, or mouth ulcers — while taking acetylcysteine, discontinue the medication immediately and contact your doctor. In very rare cases, serious cutaneous reactions such as Stevens-Johnson syndrome have been reported with mucolytic agents.
- Peptic ulcer disease: Patients with a current or previous history of gastric or duodenal ulcers should use acetylcysteine with caution, particularly if concurrently taking other medications that can irritate the gastric mucosa, such as non-steroidal anti-inflammatory drugs (NSAIDs) or corticosteroids.
- Histamine intolerance: Acetylcysteine may influence histamine metabolism. Patients with known histamine intolerance should discuss the potential risks with their doctor, as the medication may exacerbate symptoms such as headache, nasal congestion, or gastrointestinal discomfort.
- Sodium content: Each 200 mg effervescent tablet contains approximately 99 mg of sodium (about 5% of the WHO-recommended maximum daily intake of 2 g for adults). The 600 mg tablet contains approximately 139 mg sodium (about 7%). Patients on sodium-restricted diets — for example, those with heart failure, kidney disease, or hypertension — should take this into account.
Pregnancy and Breastfeeding
There is insufficient clinical data to establish the safety of oral acetylcysteine during pregnancy and breastfeeding. Animal reproductive studies have not demonstrated direct harmful effects, but adequately controlled human studies are lacking. As a precautionary measure, acetylcysteine should not be taken during pregnancy or while breastfeeding unless the prescribing physician has determined that the expected therapeutic benefit outweighs the potential risk to the fetus or infant.
If you are pregnant, think you may be pregnant, are planning to become pregnant, or are currently breastfeeding, always consult your healthcare provider before taking any medication, including acetylcysteine. Your doctor can help you evaluate the risks and benefits and may recommend alternative approaches to managing respiratory symptoms during pregnancy.
Driving and Operating Machinery
Acetylcysteine is not known to impair cognitive function, alertness, or psychomotor performance. Treatment with acetylcysteine at recommended oral doses does not affect your ability to drive vehicles or operate machinery. However, as with any medication, you should be aware of how it affects you individually. If you experience any unexpected side effects such as dizziness, exercise caution when performing tasks that require concentration.
How Does Acetylcysteine Interact with Other Drugs?
Quick Answer: Acetylcysteine can reduce the effectiveness of carbamazepine and may enhance the effects of nitroglycerin. Oral antibiotics should be taken at least 2 hours apart from acetylcysteine to avoid reduced absorption. Always inform your doctor about all medications you are taking.
Drug interactions with oral acetylcysteine are relatively limited compared to many other prescription medications, but several clinically significant interactions have been documented. It is essential to inform your doctor or pharmacist about all medicines you are currently taking, have recently taken, or might take, including over-the-counter products and herbal supplements.
Clinically Significant Interactions
| Interacting Drug | Effect | Clinical Significance | Recommendation |
|---|---|---|---|
| Carbamazepine | Reduced plasma levels of carbamazepine | Moderate — may decrease anti-epileptic efficacy | Monitor carbamazepine levels; consult your doctor |
| Nitroglycerin | Enhanced vasodilation and antiplatelet effects | Moderate — may cause increased blood pressure lowering | Use with caution; monitor blood pressure |
| Activated charcoal | Reduced absorption of oral acetylcysteine | High — relevant in overdose management | Separate administration; consider IV route |
| Oral antibiotics (tetracyclines, aminoglycosides, penicillins) | Potential reduced antibiotic absorption | Moderate — in vitro inactivation documented | Separate administration by at least 2 hours |
| Antitussive agents (cough suppressants) | Opposing pharmacological effects | Low to moderate — mucus accumulation risk | Avoid concurrent use; discuss with doctor |
Additional Considerations
The interaction between acetylcysteine and carbamazepine deserves particular attention. When these two medications are used concurrently, acetylcysteine may reduce the plasma concentration of carbamazepine, potentially decreasing its therapeutic efficacy. This is particularly important for patients with epilepsy, where subtherapeutic carbamazepine levels could increase the risk of seizures. If you are taking carbamazepine, your doctor may need to monitor your drug levels more frequently when starting or stopping acetylcysteine.
Regarding antibiotics, the interaction is primarily a physicochemical incompatibility rather than a metabolic interaction. In vitro studies have shown that acetylcysteine can inactivate certain antibiotics through its thiol group when the two are mixed directly. This does not occur when the drugs are absorbed systemically; the concern is limited to simultaneous presence in the gastrointestinal tract. Therefore, spacing oral doses by at least 2 hours typically prevents any meaningful reduction in antibiotic efficacy. Intravenous antibiotics are not affected by oral acetylcysteine.
Patients taking nitroglycerin (glyceryl trinitrate) for angina or other cardiovascular conditions should be aware that acetylcysteine may potentiate the blood-pressure-lowering and antiplatelet effects of nitroglycerin. This interaction has been observed primarily in clinical settings where both drugs are administered at higher doses. If you are prescribed both medications, your doctor will monitor your blood pressure and adjust doses as necessary.
What Is the Correct Dosage of Acetylcysteine?
Quick Answer: For adults with chronic bronchitis, the usual oral dose is 200 mg two to three times daily, or 600 mg once daily. Dissolve the effervescent tablet completely in half to one glass of water. Always follow your doctor's specific dosing instructions.
The dosage of acetylcysteine varies depending on the clinical indication, the specific formulation used, and individual patient factors. Always use this medicine exactly as your doctor or pharmacist has instructed. Do not change the dose or stop taking the medication without consulting your healthcare provider.
Adults
200 mg Effervescent Tablets
Dissolve 1 tablet in half to one glass (100–200 mL) of water. Take 2–3 times daily, providing a total daily dose of 400–600 mg. The scoring line on the 200 mg tablet is for ease of swallowing only and is not intended for dose splitting.
600 mg Effervescent Tablets
Dissolve 1 tablet in half to one glass (100–200 mL) of water. Take once daily. The 600 mg tablet can be divided into two equal halves for dose adjustment if recommended by your doctor.
Ensure that the effervescent tablet is fully dissolved before drinking. Drink the solution promptly after preparation. Acetylcysteine may be taken with or without food, although taking it with food may reduce the risk of gastrointestinal side effects in sensitive individuals.
| Patient Group | Strength | Dose | Frequency | Daily Total |
|---|---|---|---|---|
| Adults | 200 mg | 1 tablet | 2–3 times daily | 400–600 mg |
| Adults | 600 mg | 1 tablet | Once daily | 600 mg |
| Elderly | 200 or 600 mg | As for adults | As for adults | 400–600 mg |
Children and Adolescents
The oral effervescent tablet formulations of acetylcysteine described here are intended for adult use. There is no relevant pediatric indication for these specific products. If your child has respiratory symptoms requiring mucus clearance, consult a pediatrician who can recommend age-appropriate treatments and formulations.
Other formulations of acetylcysteine — such as granules for oral solution or nebulizer solutions — may be available for pediatric use in some markets. Dosing in children is weight-based and must be determined by a qualified healthcare provider.
Elderly Patients
No dose adjustment is generally required for elderly patients based solely on age. However, elderly patients are more likely to have concurrent medical conditions (such as renal or hepatic impairment) and to be taking multiple medications, which may necessitate closer monitoring. The sodium content of effervescent tablets is also a relevant consideration for elderly patients who may be on sodium-restricted diets due to cardiovascular disease.
Missed Dose
If you forget to take a dose of acetylcysteine, take it as soon as you remember — unless it is almost time for your next scheduled dose. In that case, skip the missed dose and continue with your regular dosing schedule. Do not take a double dose to make up for a forgotten one. If you have any questions about missed doses, contact your pharmacist or healthcare provider.
Overdose
If you suspect an overdose of acetylcysteine — or if a child has accidentally ingested the medication — contact your local poison control center or emergency services immediately. Symptoms of oral overdose may include dizziness, skin rash, bronchospasm, nausea, and vomiting. While oral acetylcysteine has a wide therapeutic margin and serious toxicity from oral overdose is uncommon, medical evaluation is always warranted.
What Are the Side Effects of Acetylcysteine?
Quick Answer: Common side effects include diarrhea and nausea. Less common effects include abdominal pain, bronchospasm, and allergic reactions. Serious but rare side effects such as angioedema (swelling of face/throat) require immediate medical attention.
Like all medicines, acetylcysteine can cause side effects, although not everybody gets them. Most side effects associated with oral acetylcysteine are mild and transient, primarily affecting the gastrointestinal system. Serious adverse reactions are rare but can occur. Understanding the potential side effects and knowing when to seek medical help is important for safe medication use.
Stop taking acetylcysteine and contact your doctor or emergency services immediately if you experience any of the following signs of a serious allergic reaction (angioedema): swelling of the face, tongue, or throat; difficulty swallowing; hives (urticaria) spreading over the body; or difficulty breathing. These symptoms are rare but can be life-threatening if untreated.
Common
May affect up to 1 in 10 people
- Diarrhea
- Nausea
Uncommon
May affect up to 1 in 100 people
- Abdominal pain
- Bronchospasm (airway narrowing)
- Tachycardia (rapid heartbeat)
- Hypersensitivity reactions (rash, swelling, itching)
- Breathing difficulties
- Low blood pressure (as part of allergic reaction)
Rare
May affect up to 1 in 1,000 people
- Angioedema (allergic swelling of face, lips, tongue, or throat)
- Skin rash
- Pruritus (itching)
- Urticaria (hives)
The gastrointestinal side effects (diarrhea and nausea) are the most frequently reported and are typically mild and self-limiting. They tend to occur more often at the beginning of treatment and may resolve as your body adjusts to the medication. Taking acetylcysteine with food or after meals may help reduce these symptoms.
Bronchospasm is a notable side effect of particular concern in patients with asthma or reactive airways disease. If you experience sudden wheezing, chest tightness, or shortness of breath after taking acetylcysteine, stop the medication and contact your healthcare provider. This reaction is uncommon but important to recognize, especially in predisposed individuals.
Hypersensitivity reactions can range from mild skin manifestations (rash, itching) to more serious systemic reactions. True anaphylactoid or anaphylactic reactions to oral acetylcysteine are extremely rare but are well documented in the medical literature, primarily in the context of intravenous administration for paracetamol overdose treatment. The oral formulation carries a substantially lower risk of these reactions.
Reporting Side Effects
If you experience any side effects, including any not listed above, talk to your doctor or pharmacist. You can also report suspected adverse reactions to your national pharmacovigilance authority. Reporting helps provide more information on the safety profile of this medicine and benefits all patients.
How Should You Store Acetylcysteine?
Quick Answer: Store 200 mg tablets at or below 25°C and 600 mg tablets at or below 30°C. Keep the container tightly closed to protect from moisture. Store out of the sight and reach of children.
Proper storage of acetylcysteine effervescent tablets is essential to maintain the medication's effectiveness and safety throughout its shelf life. Effervescent formulations are particularly sensitive to moisture, as exposure can trigger premature tablet disintegration and loss of potency.
- 200 mg tablets (plastic tubes): Store at or below 25°C (77°F). Keep the tube tightly closed after each use.
- 600 mg tablets (plastic tubes): Store at or below 30°C (86°F). Keep the tube tightly closed.
- Sachets (all strengths): Store at or below 30°C (86°F). Keep the sachet sealed until ready to use.
Keep this medicine out of the sight and reach of children. Do not use after the expiry date printed on the packaging (marked as “EXP”). The expiry date refers to the last day of that month. Once opened, plastic tube containers should be used within the timeframe specified on the packaging.
Do not dispose of medications via wastewater or household waste. Ask your pharmacist how to dispose of medicines you no longer use. Proper disposal helps protect the environment and prevents accidental ingestion by others.
What Does Acetylcysteine Contain?
Quick Answer: Each effervescent tablet contains either 200 mg or 600 mg of the active ingredient acetylcysteine. Inactive ingredients include citric acid, sodium bicarbonate, sodium carbonate, lactose, mannitol, ascorbic acid, saccharin sodium, sodium citrate, and blackberry flavoring.
Understanding the complete composition of your medication is important, particularly if you have known allergies or intolerances to specific ingredients. Each acetylcysteine effervescent tablet contains the following components:
Active Substance
The active pharmaceutical ingredient is acetylcysteine, present in a dose of either 200 mg or 600 mg per tablet. Acetylcysteine (chemical name: N-acetyl-L-cysteine) is a derivative of the amino acid L-cysteine and acts as both a mucolytic and a glutathione precursor.
Inactive Ingredients (Excipients)
The excipients serve various pharmaceutical functions, including effervescence generation, flavor masking, sweetening, and tablet stability:
- Anhydrous citric acid and sodium hydrogen carbonate — these create the effervescent reaction when the tablet is placed in water
- Anhydrous sodium carbonate — pH buffering agent
- Anhydrous lactose — filler/diluent (relevant for patients with lactose intolerance)
- Mannitol — sweetener and tablet excipient
- Ascorbic acid (vitamin C) — antioxidant and stabilizer
- Saccharin sodium — artificial sweetener
- Sodium citrate dihydrate — buffering agent
- Blackberry flavoring (contains sorbitol) — taste masking
- Sodium cyclamate (600 mg tablets only) — additional sweetener
This medicine contains lactose. If you have been told by your doctor that you have an intolerance to some sugars, contact your doctor before taking this medicine. It also contains sodium (99 mg per 200 mg tablet; 139 mg per 600 mg tablet) and small amounts of sorbitol. Patients on controlled sodium diets or with fructose intolerance should discuss this with their healthcare provider.
Tablet Appearance
The 200 mg tablet is a white, round, flat effervescent tablet with a score line on one side and a blackberry scent. The score line is not intended for dividing the tablet. The 600 mg tablet is similar in appearance — white, round, flat with a score line — and has a blackberry scent. The 600 mg tablet can be divided into two equal halves along the score line.
Frequently Asked Questions About Acetylcysteine
The main difference is the dosing frequency. With the 200 mg tablet, you typically take one tablet 2–3 times per day (total 400–600 mg daily). With the 600 mg tablet, you take one tablet just once per day. The 600 mg tablet may be more convenient for patients who prefer once-daily dosing. The 600 mg tablet can also be split in half, whereas the 200 mg tablet should not be divided. Both strengths deliver the same active ingredient and have comparable efficacy when the total daily dose is equivalent.
The prescription status of acetylcysteine varies by country. In some European countries, oral acetylcysteine is available over the counter (OTC) for short-term use in acute respiratory conditions. In other markets, it may require a prescription, particularly for chronic use. In the United States, acetylcysteine is available as a dietary supplement (NAC) without prescription, though the FDA-approved pharmaceutical formulation requires a prescription. Check with your local pharmacist or healthcare authority for the regulations applicable in your country.
After oral administration, acetylcysteine is rapidly absorbed, reaching peak plasma concentrations within 1–3 hours. You may begin to notice easier mucus clearance within the first few days of treatment. However, the full clinical benefit in chronic bronchitis — particularly regarding reduced exacerbation frequency — may take several weeks of consistent use to become apparent. Clinical trials evaluating exacerbation reduction in COPD have typically assessed outcomes over 3–6 months of treatment.
Acetylcysteine and NAC (N-acetylcysteine) refer to the same chemical compound. However, there are important differences between pharmaceutical-grade acetylcysteine and dietary NAC supplements. Pharmaceutical formulations undergo rigorous manufacturing standards (Good Manufacturing Practice), are subject to regulatory approval, and have well-defined bioavailability profiles. Dietary supplements may have variable quality, purity, and bioavailability. For the treatment of medical conditions such as chronic bronchitis, always use the pharmaceutical formulation as prescribed by your healthcare provider.
Yes, acetylcysteine is the standard antidote for paracetamol (acetaminophen) overdose and is listed on the WHO Model List of Essential Medicines for this indication. In overdose treatment, it is typically administered intravenously in a hospital setting using a specific weight-based dosing protocol over 21 hours. The oral formulation described in this article is intended for mucolytic use in chronic bronchitis. If you suspect a paracetamol overdose, do not attempt self-treatment — call your local poison control center or emergency services immediately.
Generally, combining acetylcysteine (a mucolytic) with a cough suppressant (antitussive) is not recommended. Acetylcysteine works by making mucus thinner and easier to cough up, while cough suppressants reduce the cough reflex. Taking both simultaneously could lead to accumulation of thinned mucus in the airways because the cough needed to clear it is suppressed. This is particularly concerning in patients with impaired mucociliary clearance. If you are unsure about combining medications, consult your doctor or pharmacist.
References
This article is based on peer-reviewed medical literature, international clinical guidelines, and official regulatory documents. All medical claims meet Evidence Level 1A standards where applicable.
- World Health Organization (WHO). WHO Model List of Essential Medicines – 23rd List. Geneva: WHO; 2023. Acetylcysteine listed as antidote for paracetamol poisoning.
- Cazzola M, Calzetta L, Page C, et al. Influence of N-acetylcysteine on chronic bronchitis or COPD exacerbations: a meta-analysis. European Respiratory Review. 2015;24(137):451-461. doi:10.1183/16000617.00002215
- Zheng JP, Wen FQ, Bai CX, et al. Twice daily N-acetylcysteine 600 mg for exacerbations of chronic obstructive pulmonary disease (PANTHEON): a randomised, double-blind placebo-controlled trial. Lancet Respiratory Medicine. 2014;2(3):187-194. doi:10.1016/S2213-2600(13)70286-8
- European Medicines Agency (EMA). Summary of Product Characteristics: Acetylcysteine effervescent tablets. Last updated 2024.
- British National Formulary (BNF). Acetylcysteine: Drug monograph. NICE Evidence Services. 2024.
- Prescott LF. Paracetamol, alcohol and the liver. British Journal of Clinical Pharmacology. 2000;49(4):291-301. doi:10.1046/j.1365-2125.2000.00167.x
- Global Initiative for Chronic Obstructive Lung Disease (GOLD). Global Strategy for the Diagnosis, Management, and Prevention of COPD. 2024 Report.
- Dekhuijzen PNR, van Beurden WJC. The role for N-acetylcysteine in the management of COPD. International Journal of COPD. 2006;1(2):99-106.
- Smilkstein MJ, Knapp GL, Kulig KW, Rumack BH. Efficacy of oral N-acetylcysteine in the treatment of acetaminophen overdose. New England Journal of Medicine. 1988;319(24):1557-1562.
- National Institute for Health and Care Excellence (NICE). Chronic obstructive pulmonary disease in over 16s: diagnosis and management. NICE guideline [NG115]. Updated 2024.
Medical Editorial Team
This article was written and reviewed by the iMedic Medical Editorial Team, comprising licensed physicians with specializations in clinical pharmacology, respiratory medicine, and toxicology. All content is based on international evidence-based guidelines (WHO, EMA, FDA, NICE, GOLD) and peer-reviewed research.
All iMedic content follows the GRADE evidence framework and is independently reviewed by board-certified medical specialists. We maintain strict editorial independence with no commercial funding or pharmaceutical industry sponsorship. Content is regularly updated to reflect the latest clinical evidence and guideline recommendations.